Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1167.7000 -5.20 (-0.44%)
NSE Jan 13, 2026 15:31 PM
Volume: 855.0K
 

1167.70
-0.44%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. is trading above its 200 day SMA of 1145.0
More from Aurobindo Pharma Ltd.
Recommended